Understanding the inflammation-cancer transformation in the development of primary liver cancer

Abstract

Primary liver cancer is one of the leading causes of cancer-related deaths worldwide. China has more than 55% liver cancer cases globally. The development of hepatocellular carcinoma (HCC) was caused by a variety of risks factors, including chronic inflammation by virus, alcohol consumption and non-alcoholic steatohepatitis. Emerging evidence has notarized inflammation as a critical component of HCC progression. The development of HCC is a multistep process which may originate from liver chronic injury and inflammation to subsequent fibrosis and/or cirrhosis and finally HCC. A large number of studies indicate that chemokines and cytokines are candidates linking molecules between inflammation and liver cancer. Here, we will describe a few of the key cytokines and chemokines and signal pathways which are involved in the inflammation of HCC. Inhibitors of inflammation for the prevention and overcoming antitumor immunity for treatment of liver cancer are promising candidates for the future management of patients with HCC.

Keywords

Inflammation / liver cancer / cytokines / chemokines / signaling pathways

References

[1] Sia D,Friedman SL.Liver cancer cell of origin, molecular class, and effects on patient prognosis.Gastroenterology2017;152:745-61

[2] Sherman M.Hepatocellular carcinoma: epidemiology, risk factors, and screening.Semin Liver Dis2005;25:143-54

[3] Nguyen VT,Dore GJ.An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025.Liver Int2008;28:525-31

[4] El-Serag HB.Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.Gastroenterology2007;132:2557-76

[5] Ikeda M,Ueno M,Ishii H.Chemotherapy for hepatocellular carcinoma: current status and future perspectives.Jpn J Clin Oncol2018;48:103-14

[6] Stroffolini T,Andriulli A,Furlan C,Morisco F,Rosina F,Smedile A.Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.PLoS One2017;12:e0185710 PMCID:PMC5687716

[7] Nakagawa H,Yoshida H,Masuzaki R,Hayakawa Y,Yamakado M,Shiina S.Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences.Int J Cancer2009;125:2264-9

[8] von Mehren M,Goldblum J,Bramwell V,Borden E.Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas.Cancer2012;118:770-6 PMCID:PMC3576704

[9] Coussens LM.Inflammation and cancer.Nature2002;420:860-7 PMCID:PMC2803035

[10] Nakagawa H.Inflammation- and stress-related signaling pathways in hepatocarcinogenesis.World J Gastroenterol2012;18:4071-81 PMCID:PMC3422785

[11] Inoue J,Shimosegawa T.Cellular membrane trafficking machineries utilized by the hepatitis viruses.Hepatology2018;

[12] Leung N.HBV and liver cancer.Med J Malaysia2005;60 Suppl B:63-6

[13] Lu J,Yang W,Lai M,Kao J,Lee H.Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy.Liver Int2005;25:752-9

[14] Di Fazio I,Musumeci S,Pistone G.Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis C.J Interferon Cytokine Res2004;24:594-9

[15] Nan J,Hu B,Dong H,Ruan D,Cai J,Chen J,Lin Z,Li X.Endoplasmic reticulum stress induced LOX-1+ CD15+ polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma.Immunology2018;154:144-55

[16] Liu M,Sun S,Feng X,Liu W,Shi Y,Xiong Y.Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.Oncogene2018;37:1637-53

[17] Rabachini T,Montani M,Sladky V,Bachmann D,Villunger A,Kaufmann T.BOK promotes chemical-induced hepatocarcinogenesis in mice.Cell Death Differ2018;25:706-18

[18] Wang B,Yu T,Qin W,Chen Y.Contradictory effects of mitochondria- and non-mitochondria-targeted antioxidants on hepatocarcinogenesis by altering DNA repair in mice.Hepatology2017;

[19] Aggarwal BB,Sandur SK,Sethi G.Inflammation and cancer: how hot is the link?.Biochem Pharmacol2006;72:1605-21

[20] Guo Y,Cao L.Hepatoprotective effect of Gan Kang Yuan against chronic liver injury induced by alcohol.J Ethnopharmacol2017;208:1-7

[21] Hamilton DL,Brown BS,Menguy RB.Liver injury with alcoholiclike hyalin after gastroplasty for morbid obesity.Gastroenterology1983;85:722-6

[22] Kaplan JM,Lahni P,Shanmukhappa SK.Obesity enhances sepsis-induced liver inflammation and injury in mice.Obesity (Silver Spring).2016;24:1480-8 PMCID:PMC4925204

[23] Kirpich I.More alcohol, more liver injury: not always true.Alcohol Alcohol2017;52:627-8

[24] Marin V,Odena G,Altamirano J,Tiribelli C,Rosso N,Nagy LE.Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients.J Hepatol2017;67:1018-25

[25] Williams JA,Ding WX.New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.World J Gastroenterol2014;20:12908-33 PMCID:PMC4177473

[26] Liu Z,Wang H,Cai Y,Lash G,Du J.Epidermal growth factor and tumor necrosis factor α cooperatively promote the motility of hepatocellular carcinoma cell lines via synergistic induction of fibronectin by NF-κB/p65.Biochim Biophys Acta2017;1861:2568-82

[27] Huang B,Wang C.Upregulation of heat shock protein 70 and the differential protein expression induced by tumor necrosis factor-alpha enhances migration and inhibits apoptosis of hepatocellular carcinoma cell HepG2.Int J Med Sci2017;14:284-93 PMCID:PMC5370291

[28] Zhang Q,Mao C,Dominah G,Zhuang Z.Fatty acid oxidation contributes to IL-1β secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration.Mol Immunol2017;94:27-35

[29] Zhang J,Lou Y,Chen Q,Yang J,Wang J,Zhang X,Bai X.Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.Hepatology2018;67:1872-89

[30] Wadkin J,Kamarajah S,Novitskaya V,Adams D,Shetty S.CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma.Am J Physiol Gastrointest Liver Physiol2017;313:G138-49 PMCID:PMC5582880

[31] Castelli G,Testa U.Liver cancer: molecular characterization, clonal evolution and cancer stem cells.Cancers (Basel).2017;9:E127 PMCID:PMC5615342

[32] Guo W,Cheng Y,Shi J,Li N,Wu M,Liu S.ICAM-1-related noncoding RNA in cancer stem cells maintains ICAM-1 expression in hepatocellular carcinoma.Clin Cancer Res2016;22:2041-50

[33] Bayo J,Fiore E,Sganga L,Andriani O,Fresno C,Fernandez E,Mazzolini G.IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness.Oncotarget2017;8:80235-48 PMCID:PMC5655193

[34] Shao Y,Li Y,Chen H,Hsu C.High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma.Jpn J Clin Oncol2017;47:949-53

[35] Hayashi T,Terashima T,Okada H,Hayashi T,Nio K,Takatori H,Sakai Y,Mizukoshi E,Kaneko S.Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.BMC Cancer2017;17:870 PMCID:PMC5738185

[36] Ding Y,Wei Y,Peng Y.Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.J Cancer Res Clin Oncol2017;143:821-34

[37] Yan B,Rabbani ZN,Li W,Li F,Li CY.Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation.Cancer Res2006;66:11565-70

[38] Lu H,Yuan X,Zhang Y,Li Z,Zhou L,Wang Q,Liu S.Role of IL-6-mediated expression of NS5ATP9 in autophagy of liver cancer cells.J Cell Physiol2017;

[39] Wu X,Lin X.Relevance of the NLRP3 inflammasome in the pathogenesis of chronic liver disease.Front Immunol2017;8:1728 PMCID:PMC5732938

[40] Karin M.The IkappaB kinase - a bridge between inflammation and cancer.Cell Res2008;18:334-42

[41] Trasino S,Jessurun J.A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.J Mol Med2016;94:1143-51 PMCID:PMC5053866

[42] Harvey W,Pu X,Cornell K,Klocke C.Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation.Toxicology2016;344-346:26-33 PMCID:PMC4792734

[43] Vanegas N.Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche.Exp Hematol Oncol2017;6:2 PMCID:PMC5223333

[44] Han K,He X,Guo X,Chen J,Nian H,Jiang M.Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma.Cancer Med2016;5:2861-71 PMCID:PMC5083740

[45] Cortes M,Stachura D,Kwan W,Vo L,Esain V,Schlaeger T,Daley G.Developmental vitamin D availability impacts hematopoietic stem cell production.Cell Rep2016;17:458-68 PMCID:PMC5338633

[46] Jeng K,Jeng W,Sheen I.Role of C-X-C chemokine ligand 12/C-X-C chemokine receptor 4 in the progression of hepatocellular carcinoma.Oncol Lett2017;14:1905-10 PMCID:PMC5529928

[47] Kisen GO,Costelli P,Schwarze PE,Seglen PO.Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells.Carcinogenesis1993;14:2501-5

[48] Silvente-Poirot S,Poirot M.Ligand-dependent transcriptional induction of lethal autophagy: a new perspective for cancer treatment.Autophagy2018;14:555-7

[49] Mi Y,Du Q,Qi G.Momordin Ic couples apoptosis with autophagy in human hepatoblastoma cancer cells by reactive oxygen species (ROS)-mediated PI3K/Akt and MAPK signaling pathways.Free Radic Biol Med2016;90:230-42

[50] Sun H,Candiotti K,Zhang Q,Wen Y,Yang J.Octreotide attenuates acute kidney injury after hepatic ischemia and reperfusion by enhancing autophagy.Sci Rep2017;7:42701 PMCID:PMC5311976

[51] Zeng Y,Li D,Chen B,Yang T.Anti-hepatocarcinoma effect of cordycepin against NDEA-induced hepatocellular carcinomas via the PI3K/Akt/mTOR and Nrf2/HO-1/NF-κB pathway in mice.Biomed Pharmacother2017;95:1868-75

[52] Vangan N,Jia X,Wang Y,Binderiya U,Li T,Wang Z.mTORC1 mediates peptidoglycan induced inflammatory cytokines expression and NF-κB activation in macrophages.Microb Pathog2016;99:111-8

[53] Sui W,Wang Z,Jia Q,Zhang W.Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H22 murine hepatocarcinoma model.Oncol Rep2014;31:2252-60

[54] Zhu Y,Wang H.New knowledge of the mechanisms of sorafenib resistance in liver cancer.Acta Pharmacol Sin2017;38:614-22 PMCID:PMC5457690

[55] Yang H,Fan J,Zhao J,Liu Q,Liu C,Sun Y.Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth.Toxicol Appl Pharmacol2017;315:90-101

[56] Johnson C.Exploiting cancer vulnerabilities: mTOR, autophagy, and homeostatic imbalance.Essays Biochem2017;61:699-710

[57] Chen H,Huang J,Wei G.Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K/Akt/NF-κB signaling pathway.Oncol Rep2017;37:865-70

[58] Zhao L,Liu F,Liu J,Liu J,Ge C.A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway.Onco Targets Ther2017;10:2115-26 PMCID:PMC5396961

[59] Wu L,Liu S,Zhang S,Zhou G.Synthesis and biological evaluation of matrine derivatives containing benzo-α-pyrone structure as potent anti-lung cancer agents.Sci Rep2016;6:35918 PMCID:PMC5081519

[60] Huang Z,Hu W,Zhang L.The study on expression of CIAPIN1 interfering hepatocellular carcinoma cell proliferation and its mechanisms.Eur Rev Med Pharmacol Sci2017;21:3054-60

[61] Zhu AX,Assenat E,Kang YK,Poon RT,Vogel A.Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.JAMA2014;312:57-67

[62] Chen J,Xia H,Kong S,Seshachalam V,Goh B,Hong W.The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.Gut2016;65:1522-34 PMCID:PMC5036256

[63] Levrero M.Mechanisms of HBV-induced hepatocellular carcinoma.J Hepatol2016;64:S84-101

[64] Liang Y,Zong M,Lee J,Li H,Wu ZJ.β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET.Hepatology2018;67:1807-22

[65] Yin Y,Li S,Shi J.TLR4 Influences hepatitis B virus related hepatocellular carcinoma by regulating the Wnt/β-catenin pathway.Cell Physiol Biochem2017;42:469-79

[66] Wang S,Srivastava R,Go G,Iwakiri Y.Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a.FASEB J2015;29:3436-45 PMCID:PMC4511193

[67] Kyriakis J.Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update.Physiol Rev2012;92:689-737

[68] Pu W,Zheng Y,Fan X,He J,Liu X,Yang S,Liu L,Wei Y.Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development.Hepatology2018;

[69] Zhang R,Bai L,Li R,Liu Y,Liu F.The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.Mol Carcinog2015;54:1554-66

[70] Zhang Y,Li X,Wang L,Zhang X,Niu J,Ren Z.microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway.Cell Death Dis2018;9:130 PMCID:PMC5833540

[71] Pinna F,Beuke K,Longerich T,Schirmacher P,Breuhahn K.A20/TNFAIP3 discriminates tumor necrosis factor (TNF)-induced NF-κB from JNK pathway activation in hepatocytes.Front Physiol2017;8:610 PMCID:PMC5572400

[72] Stebbins J,Machleidt T,Vazquez J,Chen L,Riel-Mehan M,Solinas G,Pellecchia M.Identification of a new JNK inhibitor targeting the JNK-JIP interaction site.Proc Natl Acad Sci U S A2008;105:16809-13 PMCID:PMC2567907

[73] Nagata H,Tada M,Kitamura K,Narita M,Tamaki N,Ikai I,Uemoto S.Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.Hepatology2009;49:1944-53

[74] Wu H,Liu H,Wang Y.Both classic Gs-cAMP/PKA/CREB and alternative Gs-cAMP/PKA/p38β/CREB signal pathways mediate exenatide-stimulated expression of M2 microglial markers.J Neuroimmunol2018;316:17-22

[75] Yang S,Qu X,Zhang Q.Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC.Mol Med Rep2017;15:719-23 PMCID:PMC5364870

[76] Rudalska R,Longerich T,Wuestefeld T,Hohmeyer A,Leibold J.In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.Nat Med2014;20:1138 PMCID:PMC4587571

[77] Verma A,Anwar F,Al-Abbasi F.Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway.Inflammopharmacology2018;26:133-46

[78] Dai W,Zhang S,Xu X,Wang J.Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2.Int J Biochem Cell Biol2017;89:157-70

[79] Sghaier I,Rabia N,Ghazoueni E,Loueslati B.Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients.Cytokine2017;89:62-7

[80] Marquardt J,Arreguin Camacho L,Lee Y,Domínguez M,Breuhahn K,Galle P,Factor V.Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.J Hepatol2015;63:661-9 PMCID:PMC4543531

[81] Ren L,Dai C,Wang Y,Liu C.Chrysophanol inhibits proliferation and induces apoptosis through NF-κB/cyclin D1 and NF-κB/Bcl-2 signaling cascade in breast cancer cell lines.Mol Med Rep2018;17:4376-82

[82] Liang J,Wu X,Wu J,Luo D,Liu Y,Chen J.Protective effect of patchoulene epoxide against ethanol-induced gastric ulcer in rats: influence on oxidative stress, inflammation and apoptosis.Chem Biol Interact2018;283:30-7

[83] Tsai J,Hsu F.Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.Oncol Rep2017;37:1036-44

[84] Yu X,Hou X,Lu N,Jiao C,Zhang C.HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.J Hepatol2017;66:693-702

[85] Best B,Ren B.VEGF/PKD-1 signaling mediates arteriogenic gene expression and angiogenic responses in reversible human microvascular endothelial cells with extended lifespan.Mol Cell Biochem2018;

[86] Han J,Gao P,Liu H,Lu W,Lv F,Bie X.The antibacterial activity of LI-F type peptide against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and inhibition of infections in murine scalded epidermis.Appl Microbiol Biotechnol2018;102:2301-11

[87] Choi S,Kim W,Choi S.VEGF overexpression predicts poor survival in hepatocellular carcinoma.Open Med (Wars).2017;12:430-9

[88] Li X,Guan S,Liu L.Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a systematic review.Oncotarget2017;8:93179-85

[89] Darnell JEJr,Stark GR.Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.Science1994;264:1415-21

[90] Wang S.The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review)..Int J Oncol2014;44:1032-40

[91] Zheng Y,Zhao H.Effect of matrine and oxymatrine on proliferation and expression of Stat3 and Stat5 in SMMC-7721 cell line.Zhongguo Zhong Yao Za Zhi2008;33:2234-7(in Chinese)

[92] Wonganan O,Shen X,Suksamrarn A,Wang F.6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.Toxicol Appl Pharmacol2017;336:31-9

[93] Ilamathi M,Ayyappa K.Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling.Biomed Pharmacother2016;82:72-9

[94] Zhou G,Jin L,Fang P,Zheng Y.The protective effect of juglanin on fructose-induced hepatitis by inhibiting inflammation and apoptosis through TLR4 and JAK2/STAT3 signaling pathways in fructose-fed rats.Biomed Pharmacother2016;81:318-28

[95] Wang B,Wu J,Chen R,Xu M.STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.Biomed Pharmacother2017;98:214-21

[96] Sihver W,Krause M,Steinbach J.Radiolabeled cetuximab conjugates for EGFR targeted cancer diagnostics and therapy.Pharmaceuticals (Basel).2014;7:311-38 PMCID:PMC3978494

[97] Tan X,Rapraeger A.Stress-induced EGFR trafficking: mechanisms, functions, and therapeutic implications.Trends Cell Biol2016;26:352-66 PMCID:PMC5120732

[98] Dang Z,Zhang C,Ren Y,Xiang H.Loss of protocadherin-17 (PCDH-17) promotes metastasis and invasion through hyperactivation of EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma.Tumour Biol2016;37:2527-35

[99] Wang R,Chen H,Li L,Jiang F,Liu G,Chen C,Chang Y,Zhang J,Huang G,Wu M,Wang H.MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.Gastroenterology2013;145:1436-48.e1-12

[100] Li R,Wubin H,Jianhua H,Rongjian S.Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells.Oncotarget2017;8:19354-64

[101] Chen L,Zheng L,Liang G.Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases.Drug Discov Today2018;23:1187-202

[102] Uthaya Kumar D,Liu J,Sher L,DiNorcia J,Naini B,Agopian V,Machida K.TLR4 signaling via NANOG cooperates with STAT3 to activate Twist1 and promote formation of tumor-initiating stem-like cells in livers of mice.Gastroenterology2016;150:707-19 PMCID:PMC4766021

[103] Wen J,Chen W,Chen J,Huang Y,Wang G,Zhou S.Oxymatrine improves intestinal epithelial barrier function involving NF-κB-mediated signaling pathway in CCl4-induced cirrhotic rats.PLoS One2014;9:e106082 PMCID:PMC4149463

[104] Miyazaki M,Inoue M,Miyatake H,Yakushijin T,Hiramatsu N,Kasahara A.Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.J Med Virol2008;80:980-8

[105] Liu M,Han X,Xu L,Zhao Y,Peng J.Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway.Sci Rep2015;5:18038 PMCID:PMC4674875

[106] Heger M,Broekgaarden M.The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer.Pharmacol Rev2014;66:222-307

[107] Kadasa N,Afifi M.Hepatoprotective effects of curcumin against diethyl nitrosamine induced hepatotoxicity in albino rats.Asian Pac J Cancer Prev2015;16:103-8

[108] El-Houseini M,Sakr M.Novel protective role of curcumin and taurine combination against experimental hepatocarcinogenesis.Exp Ther Med2017;13:29-36 PMCID:PMC5244977

[109] Halls C.Potential for metabolic engineering of resveratrol biosynthesis.Trends Biotechnol2008;26:77-81

[110] Yu H,Zhao S,Zhang H.Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells.Biomed Pharmacother2008;62:366-72

[111] Uchida Y,Watanabe S,Meng Y,Kasai A,Yao J.Enhancement of NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells.Clin Exp Immunol2005;142:76-83 PMCID:PMC1809482

[112] Chai R,Zheng Z,Ji S.Resveratrol inhibits proliferation and migration through SIRT1 mediated post translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells.Mol Med Rep2017;16:8037-44 PMCID:PMC5779887

[113] Piotrowska H,Nowicki M,Ignatowicz E,Zawierucha P,Murias M.Effect of resveratrol analogue, DMU-212, on antioxidant status and apoptosis-related genes in rat model of hepatocarcinogenesis.Hum Exp Toxicol2017;36:160-75

[114] Zhang Z,Yao Z,Shao J,Zhang F.Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.Redox Biol2017;11:322-34 PMCID:PMC5199192

[115] Zaki S,Motawie A.N-acetylcysteine versus progesterone on the cisplatin-induced peripheral neurotoxicity.Folia Morphol (Warsz).2018;77:234-45

[116] Cheng B,Kuang A,Scofield V.N-acetylcysteine in combination with IGF-1 enhances neuroprotection against proteasome dysfunction-induced neurotoxicity in SH-SY5Y cells.Parkinsons Dis2016;2016:6564212

[117] Lima K,Schuster A,Basso B,Pedrazza L,Martha B,Chiela E,Thomé M,Dias H,De Oliveira J.Gallic acid reduces cell growth by induction of apoptosis and reduction of IL-8 in HepG2 cells.Biomed Pharmacother2016;84:1282-90

[118] Sun G,Xie Y,Zhao W.Gallic acid as a selective anticancer agent that induces apoptosis in SMMC-7721 human hepatocellular carcinoma cells.Oncol Lett2016;11:150-8 PMCID:PMC4727056

[119] Song M,Song M,Park Y.Polycyclic aromatic hydrocarbons induce migration in human hepatocellular carcinoma cells (HepG2) through reactive oxygen species-mediated p38 MAPK signal transduction.Cancer Sci2011;102:1636-44

[120] Bie B,Li J,Jiang W,Yang J.Baicalein, a natural anti-cancer compound, alters microRNA expression profiles in Bel-7402 human hepatocellular carcinoma cells.Cell Physiol Biochem2017;41:1519-31

[121] Gong W,Liu B,Dong J.Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors.Eur J Med Chem2017;126:844-52

[122] Igbe I,Jiao W,Deng T,Liu W,Zhang G.Dietary quercetin potentiates the antiproliferative effect of interferon-α in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase.Oncotarget2017;8:113734-48 PMCID:PMC5768359

[123] Ren K,Wu G,Lu H,Han X.Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells.Int J Oncol2017;50:1299-311

[124] Ma Y,Liu L,Chen X,Sun X.Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.Cancer Lett2011;301:75-84

[125] Babu L,Balasubramanian M.Myrtenal, a natural monoterpene, down-regulates TNF-α expression and suppresses carcinogen-induced hepatocellular carcinoma in rats.Mol Cell Biochem2012;369:183-93

[126] Zaghloul R,Kenawy H,Eissa L.Hepatoprotective effect of hesperidin in hepatocellular carcinoma: involvement of Wnt signaling pathways.Life Sci2017;185:114-25

[127] Lin X,Huang C,Meng X,Wang Q.Hesperetin derivative-7 inhibits PDGF-BB-induced hepatic stellate cell activation and proliferation by targeting Wnt/β-catenin pathway.Int Immunopharmacol2015;25:311-20

[128] Zhang J,Wu D,Dong W.Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium.Med Oncol2015;32:101

[129] Lee K,Kao S,Liu C,Yeh C.The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kappaB in human hepatocellular carcinoma cells.Toxicol Lett2010;194:42-9

[130] Xu X,Zhao L,Bu W,Gu Z,Zheng C,Sun H.Aspirin-based carbon dots, a good biocompatibility of material applied for bioimaging and anti-inflammation.ACS Appl Mater Interfaces2016;8:32706-16

[131] Abdelmonsif D,El-Hadidy W.Targeting AMPK, mTOR and β-catenin by combined metformin and aspirin therapy in HCC: an appraisal in Egyptian HCC patients.Mol Diagn Ther2018;22:115-27

[132] Xia H.Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer.Cell Death Dis2017;8:e3112 PMCID:PMC5682678

[133] Márquez-Rosado L,García-Cuéllar C.Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats.J Hepatol2005;43:653-60

[134] Behari J,Otruba W,Muller P,Sekhon S,Monga S.R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.J Hepatol2007;46:849-57 PMCID:PMC1924913

[135] Nagahara T,Fujise Y,Murawaki Y.Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats.Biomed Pharmacother2010;64:319-26

[136] Yin G,Han S,Liu Q.Downregulation of HSP70 gene expression and apoptosis in human hepatocellular carcinoma SMMC-7721 cells induced by nimesulide in vitro.Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi2012;28:933-6(in Chinese)

[137] Pei Q,Yang M,Liu J.Roxithromycin inhibits VEGF-induced human airway smooth muscle cell proliferation: Opportunities for the treatment of asthma.Exp Cell Res2016;347:378-84

[138] Ding D,Jiang W,Zhu H,Saiyin H,Huang H,Yu L.Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.Oncogene2017;36:6691-700

[139] Chen L,Liu Z,Liu Q,Chen Z,Zhu H.Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway.Oncol Rep2018;39:1081-9

[140] Kaseb A,Iwasaki M,Raghav K,Cheung S,Elsayes K,Abdel-Wahab R,Hassan M,Wolff R.Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma.Onco Targets Ther2016;9:773-80 PMCID:PMC4760665

[141] Finn R.Emerging targeted strategies in advanced hepatocellular carcinoma.Semin Liver Dis2013;33 Suppl 1:S11-9

[142] Wu Z,Liu J,Wendum D,Paradis V.Neurotensin regulation induces overexpression and activation of EGFR in HCC and restores response to erlotinib and sorafenib.Cancer Lett2017;388:73-84

[143] Villanueva A.The transition from inflammation to cancer in the liver.Clinical Liver Disease2016;8:89-93

[144] El-Khoueiry AB,Yau T,Kudo M,Kim TY,Trojan J.Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.Lancet2017;389:2492-502